Moolec Science (MLEC) Amortizatization of Intangibles (2023 - 2024)

Moolec Science's (MLEC) quarterly Amortizatization of Intangibles came in at $7040.0 in Q4 2024, down 80.59% year-on-year from $36273.0 in Q1 2024, and down 81.82% quarter-over-quarter from $38732.0 in Q3 2024.

Moolec Science (MLEC) Amortizatization of Intangibles (2023 - 2024) Analysis & Trends

Moolec Science has disclosed Amortizatization of Intangibles across 2 years of filings, most recently posting $7040.0 for Q4 2024.

  • Amortizatization of Intangibles for Q4 2024 came in at $7040.0, down 80.59% year-over-year; the trailing twelve-month figure through Dec 2024 was $12.1 million (changed N/A YoY), and the FY2025 annual result was $11.2 million, down 7.53% from the prior year.
  • Amortizatization of Intangibles came in at $7040.0 for Q4 2024 at Moolec Science, down from $38732.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $11.6 million in Q2 2024 to a low of $7040.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 13,267.00
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn -
9 Abivax 94.26 Bn 94.26 Bn - -
10 Moolec Science 6.98 Bn 6.98 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 7,040.00
Dec 31, 2024 7,040.00
Sep 30, 2024 38,732.00
Sep 30, 2024 38,732.00
Jun 30, 2024 11.59 Mn
Jun 30, 2024 11.59 Mn
Mar 31, 2024 479,022.00
Mar 31, 2024 479,022.00
Dec 31, 2023 36,273.00
Dec 31, 2023 36,273.00
Sep 30, 2023 9,894.00
Sep 30, 2023 9,894.00